Network-driven plasma proteomics expose molecular changes in the Alzheimer's brain.

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Sporadic Alzheimer's disease (AD) biological pathways remain largely unknown.
• Cognitive symptoms manifest decades after molecular onset, hindering early research.
• Molecular research is often limited to late-stage post-mortem brain tissue studies.

Purpose of the Study:

• To identify molecular pathways contributing to sporadic Alzheimer's disease.
• To explore the link between cellular pathology and circulatory signaling proteins.
• To develop novel diagnostic or therapeutic strategies for Alzheimer's disease.

Main Methods:

• Probed relative levels of ~600 secreted signaling proteins in blood using antibody microarrays.
• Mapped disease-specific molecular networks from protein data.
• Utilized independent genome and transcriptome data to corroborate pathways.

Main Results:

• Identified Growth-Differentiation Factor (GDF) signaling as a novel Alzheimer's disease-relevant pathway.
• Confirmed the link between cellular pathology and circulatory signaling proteins through in vivo and in vitro experiments.
• Demonstrated the informative nature of secreted signaling molecules in blood for Alzheimer's research.

Conclusions:

• Growth-Differentiation Factor (GDF) signaling represents a significant, previously unrecognized pathway in Alzheimer's disease.
• Circulatory signaling proteins provide accessible information about early, otherwise unobservable, molecular pathology.
• This study opens new avenues for early Alzheimer's detection and intervention.